Literature DB >> 28692847

Microbial metabolites are associated with a high adherence to a Mediterranean dietary pattern using a 1H-NMR-based untargeted metabolomics approach.

Enrique Almanza-Aguilera1, Mireia Urpi-Sarda2, Rafael Llorach3, Rosa Vázquez-Fresno1, Mar Garcia-Aloy3, Francesc Carmona4, Alex Sanchez5, Francisco Madrid-Gambin3, Ramon Estruch6, Dolores Corella7, Cristina Andres-Lacueva8.   

Abstract

The study of biomarkers of dietary patterns including the Mediterranean diet (MedDiet) is scarce and could improve the assessment of these patterns. Moreover, it could provide a better understanding of health benefits of dietary patterns in nutritional epidemiology. We aimed to determine a robust and accurate biomarker associated with a high adherence to a MedDiet pattern that included dietary assessment and its biological effect. In this cross-sectional study, we included 56 and 63 individuals with high (H-MDA) and low (L-MDA) MedDiet adherence categories, respectively, all from the Prevención con Dieta Mediterránea trial. A 1H-NMR-based untargeted metabolomics approach was applied to urine samples. Multivariate statistical analyses were conducted to determine the metabolite differences between groups. A stepwise logistic regression and receiver operating characteristic curves were used to build and evaluate the prediction model for H-MDA. Thirty-four metabolites were identified as discriminant between H-MDA and L-MDA. The fingerprint associated with H-MDA included higher excretion of proline betaine and phenylacetylglutamine, among others, and decreased amounts of metabolites related to glucose metabolism. Three microbial metabolites - phenylacetylglutamine, p-cresol and 4-hydroxyphenylacetate - were included in the prediction model of H-MDA (95% specificity, 95% sensitivity and 97% area under the curve). The model composed of microbial metabolites was the biomarker that defined high adherence to a Mediterranean dietary pattern. The overall metabolite profiling identified reflects the metabolic modulation produced by H-MDA. The proposed biomarker may be a better tool for assessing and aiding nutritional epidemiology in future associations between H-MDA and the prevention or amelioration of chronic diseases.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Biomarkers; Dietary patterns; High adherence; Mediterranean diet; Metabolomics; Microbiota

Mesh:

Substances:

Year:  2017        PMID: 28692847     DOI: 10.1016/j.jnutbio.2017.06.001

Source DB:  PubMed          Journal:  J Nutr Biochem        ISSN: 0955-2863            Impact factor:   6.048


  11 in total

Review 1.  The phenolic interactome and gut microbiota: opportunities and challenges in developing applications for schizophrenia and autism.

Authors:  George E Jaskiw; Mark E Obrenovich; Curtis J Donskey
Journal:  Psychopharmacology (Berl)       Date:  2019-06-13       Impact factor: 4.530

2.  MtpB, a member of the MttB superfamily from the human intestinal acetogen Eubacterium limosum, catalyzes proline betaine demethylation.

Authors:  Jonathan W Picking; Edward J Behrman; Liwen Zhang; Joseph A Krzycki
Journal:  J Biol Chem       Date:  2019-07-24       Impact factor: 5.157

3.  1H NMR-Based Metabolomics Reveals the Intrinsic Interaction of Age, Plasma Signature Metabolites, and Nutrient Intake in the Longevity Population in Guangxi, China.

Authors:  He Li; Minhong Ren; Quanyang Li
Journal:  Nutrients       Date:  2022-06-18       Impact factor: 6.706

Review 4.  Accelerating the Search for Interventions Aimed at Expanding the Health Span in Humans: The Role of Epidemiology.

Authors:  Anne B Newman; Stephen B Kritchevsky; Jack M Guralnik; Steven R Cummings; Marcel Salive; George A Kuchel; Jennifer Schrack; Martha Clare Morris; David Weir; Andrea Baccarelli; Joanne M Murabito; Yoav Ben-Shlomo; Mark A Espeland; James Kirkland; David Melzer; Luigi Ferrucci
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2020-01-01       Impact factor: 6.591

5.  Application of 1H-NMR Metabolomics for the Discovery of Blood Plasma Biomarkers of a Mediterranean Diet.

Authors:  Shirin Macias; Joseph Kirma; Ali Yilmaz; Sarah E Moore; Michelle C McKinley; Pascal P McKeown; Jayne V Woodside; Stewart F Graham; Brian D Green
Journal:  Metabolites       Date:  2019-09-27

6.  1H-NMR Metabolomics Analysis of the Effect of Rubusoside on Serum Metabolites of Golden Hamsters on a High-Fat Diet.

Authors:  Li Li; Manjing Jiang; Yaohua Li; Jian Su; Li Li; Xiaosheng Qu; Lanlan Fan
Journal:  Molecules       Date:  2020-03-11       Impact factor: 4.411

Review 7.  The Study of Relationship between Nutritional Behaviors and Metabolic Indices: A Systematic Review.

Authors:  Sarah Nouriyengejeh; Bahare Seyedhoseini; Parastou Kordestani-Moghadam; Ata Pourabbasi
Journal:  Adv Biomed Res       Date:  2020-10-30

8.  Urinary metabolic biomarkers of diet quality in European children are associated with metabolic health.

Authors:  Nikos Stratakis; Alexandros P Siskos; Eleni Papadopoulou; Hector C Keun; Leda Chatzi; Anh N Nguyen; Yinqi Zhao; Katerina Margetaki; Chung-Ho E Lau; Muireann Coen; Lea Maitre; Silvia Fernández-Barrés; Lydiane Agier; Sandra Andrusaityte; Xavier Basagaña; Anne Lise Brantsaeter; Maribel Casas; Serena Fossati; Regina Grazuleviciene; Barbara Heude; Rosemary Rc McEachan; Helle Margrete Meltzer; Christopher Millett; Fernanda Rauber; Oliver Robinson; Theano Roumeliotaki; Eva Borras; Eduard Sabidó; Jose Urquiza; Marina Vafeiadi; Paolo Vineis; Trudy Voortman; John Wright; David V Conti; Martine Vrijheid
Journal:  Elife       Date:  2022-01-25       Impact factor: 8.140

Review 9.  Metabolic and Vascular Effect of the Mediterranean Diet.

Authors:  Antonino Tuttolomondo; Irene Simonetta; Mario Daidone; Alba Mogavero; Antonella Ortello; Antonio Pinto
Journal:  Int J Mol Sci       Date:  2019-09-23       Impact factor: 5.923

Review 10.  Advances in dietary pattern analysis in nutritional epidemiology.

Authors:  Christina-Alexandra Schulz; Kolade Oluwagbemigun; Ute Nöthlings
Journal:  Eur J Nutr       Date:  2021-04-25       Impact factor: 5.614

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.